Ga-68 P16-093

· Five Eleven Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ga-68 P16-093, covering 2022-05-02 to 2022-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer [Phase 1, Phase 2]